Abstract:
:Research into how the central nervous system (CNS) and the skin of mammals are physiologically connected and how this "brain-skin connection" may be therapeutically targeted in clinical medicine has witnessed a renaissance. A key element in this development has been the discovery that mammalian skin and its appendages, namely human scalp hair follicles (HFs), not only are important, long-underestimated target tissues for classical neurohormones, neurotrophins and neuropeptides, but also are eminent peripheral tissue sources for the production and/or release of these neuromediators. This essay summarizes the many different levels of biology at which human scalp HFs respond to and generate a striking variety of neurohormones, and portrays HFs as prototypic, cyclically remodelled miniorgans that utilize these neurohormones to autoregulate their growth, hair shaft production, rhythmic organ transformation, pigmentation, mitochondrial energy metabolism, and immune status. The essay also explores how preclinical research on human scalp HFs can be exploited to unveil and explore "novel" and clinically as yet untapped, but most likely ancestral functions of neurohormones within mammalian epithelial biology that still impact substantially on human skin physiology. Arguably, systematic investigation of the "brain-skin connection" is one of the most intriguing current research frontiers in investigative dermatology, not the least since it has reversed the traditional CNS focus in studying the interactions between two key organ systems by placing the skin epithelium on center stage.
journal_name
Curr Res Transl Medjournal_title
Current research in translational medicineauthors
Paus Rdoi
10.1016/j.retram.2016.10.003subject
Has Abstractpub_date
2016-01-01 00:00:00pages
207-214issue
4issn
2452-3186pii
S2452-3186(16)30070-8journal_volume
64pub_type
杂志文章,评审abstract:PURPOSE OF THE STUDY:Two chimeric antigen receptor (CAR) T-cell therapies - Tisagenlecleucel (Kymriah™) and Axicabtagene ciloleucel (Yescarta™) - have been approved for commercial use. In order to inform forthcoming EBMT guidelines on the management of adults and children undergoing autologous CAR T-cell therapy, we un...
journal_title:Current research in translational medicine
pub_type: 杂志文章
doi:10.1016/j.retram.2019.05.002
更新日期:2019-08-01 00:00:00
abstract::Graft-versus-host disease (GvHD) is a common complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) with high morbidity and mortality rates. The purpose of this study was to demonstrate the efficacy of Manual Lymph Drainage (MLD) and a home-based exercise programme on range of motion (ROM) and ...
journal_title:Current research in translational medicine
pub_type: 杂志文章
doi:10.1016/j.retram.2019.11.001
更新日期:2020-01-01 00:00:00
abstract::Diabetic retinopathy (DR) and retinopathy of prematurity (ROP) present two examples of proliferative retinopathy, characterized by the same stages of progression; ischemia of the retinal vessels, leads to hypoxia and to correct the problem there is the setting up of uncontrolled angiogenesis, which subsequently causes...
journal_title:Current research in translational medicine
pub_type: 杂志文章,评审
doi:10.1016/j.retram.2019.01.005
更新日期:2019-05-01 00:00:00
abstract::Hyper IgM (HIGM) syndromes are a complex of primary immunodeficiency disorders. A 4-years-old boy with recurrent fever and chills, dyspnea, sort throat for a month was admitted to emergency department. In the current case, whole exome sequencing followed by Sanger sequencing were employed in order to screen probable f...
journal_title:Current research in translational medicine
pub_type: 杂志文章
doi:10.1016/j.retram.2018.02.001
更新日期:2019-02-01 00:00:00
abstract:PURPOSE OF THE STUDY:While acute graft-versus-host-disease (GVHD) is a T cell-mediated disease caused by alloreactive donor T cells, we and others have highlighted that patients who received higher proportion of donor CD4+ naïve and central memory T cells expressing the chemokine receptor 7 (CCR7) more often developed ...
journal_title:Current research in translational medicine
pub_type: 杂志文章
doi:10.1016/j.retram.2018.11.002
更新日期:2019-02-01 00:00:00
abstract::Heterogeneous practices exist across transplant centres regarding assessment prior to allogeneic haematopoietic cell transplantation (allo-HCT) for myelofibrosis, post-transplant monitoring and management of relapse. The 'Practice Harmonisation and Guidelines' and Myeloproliferative Neoplasms subcommittees of the Chro...
journal_title:Current research in translational medicine
pub_type: 杂志文章
doi:10.1016/j.retram.2020.08.003
更新日期:2020-10-15 00:00:00
abstract::Based on animal studies and serendipitous clinical cases, haematopoietic stem cell transplantation (HSCT) has been used since 1995 as a specific treatment for patients with severe treatment-resistant autoimmune disease (ADs). Despite other clinical developments for autoimmune diseases, including biological therapies, ...
journal_title:Current research in translational medicine
pub_type: 杂志文章,评审
doi:10.1016/j.retram.2016.03.003
更新日期:2016-04-01 00:00:00
abstract::Studies have shown that the NRF-2 /HO-1 pathway participates in myocardial ischemic reperfusion injury (MI/R) and that Geniposide (GEN) could protect the myocardial against MI/R. This study aims to examine the protective effects of GEN on MI/R in diabetic rats and further explore the possible mechanism of action. Duri...
journal_title:Current research in translational medicine
pub_type: 杂志文章
doi:10.1016/j.retram.2019.03.002
更新日期:2019-05-01 00:00:00
abstract:PURPOSE OF THE STUDY:Mesenchymal stromal cells (MSCs) are considered a promising tool for cell therapy approaches. The translation of research-based cell culture protocols into procedures that comply with Good Manufacturing Practice (GMP) is critical. The aim of this study was to design a new method for the expansion o...
journal_title:Current research in translational medicine
pub_type: 杂志文章
doi:10.1016/j.retram.2018.06.002
更新日期:2019-02-01 00:00:00
abstract::The development of genomic editing technologies expands the landscape of T cell engineering for adoptive cell therapy. Among the multiple tools that can be used, CRISPR/Cas9 has been shown to be relatively easy to use, simple to design and cost effective with highly efficient multiplex genome engineering capabilities....
journal_title:Current research in translational medicine
pub_type: 杂志文章,评审
doi:10.1016/j.retram.2018.04.003
更新日期:2018-05-01 00:00:00